Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q1
$7.79M Buy
151,611
+42,517
+39% +$2.15M 0.1% 268
2013
Q4
$5.76M Buy
109,094
+9,446
+9% +$464K 0.07% 314
2013
Q3
$4.46M Sell
99,648
-289,893
-74% -$12.9M 0.06% 338
2013
Q2
$16.1M Buy
+389,541
New +$17M 0.22% 127

Other funds holding ABBV

F&C Asset Management's ABBV Position: Q1 2014 in Review

F&C Asset Management increased its AbbVie (ABBV) stake by 39% in Q1 2014, buying an estimated $2.15M and bringing the position to 151,611 shares worth $7.79M. The position accounts for 0.1% of the portfolio, ranked #268.

F&C Asset Management first reported a position in ABBV in Q2 2013 and has held it in 4 quarters since. The position peaked at $16.1M in Q2 2013. 1,422 funds tracked by Wall St. Rank hold ABBV as of Q1 2014.

  • F&C Asset Management held 151,611 shares of AbbVie worth $7.79M as of Q1 2014.
  • F&C Asset Management bought 42,517 AbbVie shares in Q1 2014, an estimated $2.15M.
  • AbbVie made up 0.1% of F&C Asset Management's portfolio in Q1 2014, its #268 holding.
  • F&C Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 4 quarters since.
  • F&C Asset Management's AbbVie position peaked at $16.1M in Q2 2013.
  • 1,422 funds tracked by Wall St. Rank held AbbVie as of Q1 2014.

Based on F&C Asset Management's 13F filing for Q1 2014, filed 14 May 2014.